Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3637621017 | Enasidenib | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3637622012 | Enasidenib (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Enasidenib | Is a | Aminopyridine | true | Inferred relationship | Some | ||
| Enasidenib | Has disposition (attribute) | Isocitrate dehydrogenase-2 inhibitor (disposition) | true | Inferred relationship | Some | ||
| Enasidenib | Is a | Substance with isocitrate dehydrogenase-2 inhibitor mechanism of action (substance) | true | Inferred relationship | Some | ||
| Enasidenib | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Enasidenib | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Enasidenib mesilate (substance) | Is a | False | Enasidenib | Inferred relationship | Some | |
| Product containing enasidenib (medicinal product) | Has active ingredient | True | Enasidenib | Inferred relationship | Some | 1 |
| Product containing enasidenib in oral dose form (medicinal product form) | Has active ingredient | True | Enasidenib | Inferred relationship | Some | 1 |
| Enasidenib mesilate (substance) | Is modification of (attribute) | True | Enasidenib | Inferred relationship | Some | |
| Enasidenib only product | Has active ingredient | True | Enasidenib | Inferred relationship | Some | 1 |
| Product containing only enasidenib in oral dose form (medicinal product form) | Has active ingredient | True | Enasidenib | Inferred relationship | Some | 1 |
Reference Sets
FHIR